CannabIP: U.S. Patent No. 10,334,796 B2
U.S. Patent No. 10,334,796 B1 issued on July 2, 2019, for “Methods and Systems of Cultivation,” to inventors Eric Speidell and Kyle Speidel of Denver, Colorado. The applicant/assignee is MJ Brain...
U.S. Patent No. 10,334,796 B1 issued on July 2, 2019, for “Methods and Systems of Cultivation,” to inventors Eric Speidell and Kyle Speidel of Denver, Colorado. The applicant/assignee is MJ Brain...
Patent, copyright, and trademark are the three most common and well-known IPs. However, there are many other IPs. Three types of IPs protecting new plant varieties, or plant breeder’s rights, are...
U.S. Patent No. 10,279,000 B1 (‘000) issued on May 7, 2019, for “Method for Treating Cannabis Induced Anxiety.” It was issued to inventor Mark Hetherington, of Saskatoon, Canada and Jason Green, of...
On August 21, 2019, the Court of Appeals for the Federal Circuit held in The Chamberlain Group, Inc. v. Techtronic Inds. Co., that Chamberlain’s U.S. Patent No. 7,224,275 (‘275) directed to wireless...
On September 18, 2019, the National Institute of Standards and Technology (NIST)’s Genome Editing Consortium (GEC) formally sought comments on genome editing, commonly called CRISPR, terminology in...
There have been several patent-eligibility rulings by the Court of Appeals for the Federal Circuit this year, but on August 16, 2019, the Fed Circuit held that claim construction in-dispute must be...
U.S. Patent No. 10,258,601 B1 (‘601) issued on April 16, 2019, for “Vaporizable Cannabinoid Compositions.” It was issued to applicant/inventor Stephen C. Perry, of Norwood, Massachusetts. The...
In a strange ruling by the Court of Appeals for the Federal Circuit, on July 29, 2019, although publicly released on August 9, 2019, in Genetic Veterinary Scis., Inc. v. Laboklin GmbH & Co KG, the...
U.S. Patent No. PP30,668 P3 (‘668) issued on July 9, 2019, for “Cannabis Plant Named ‘DD-CT-BR5’.” It was issued to inventor David Holmes of San Gabriel, California. The applicant/assignee is...
Many cases have been heard before the Court of Appeals for the Federal Circuit dealing with substantive patent issues, like questions involving anticipation under 35 U.S.C. §102, obviousness under 35...